All In MedTech

FDA Clearance Tracker · P840001-S512

Pain Rechargeable (RC) Spinal Cord Stimulation (SCS) System: Inceptiv LT Implantable Neurostimulator (Model 977117); Int

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 24, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 24, 2024

Approved

Time to decision

785 days

Received Mar 1, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P840001-S512
Device name
Pain Rechargeable (RC) Spinal Cord Stimulation (SCS) System: Inceptiv LT Implantable Neurostimulator (Model 977117); Int
Applicant location
Minneapolis, MN
Received
Mar 1, 2022
Decided
Apr 24, 2024
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P840001

Device type

Device class
Class III

Every decision under product code LGW

FDA's approval statement

As written in FDA's record.

approval for the Pain RC SCS System including: 1) the new Inceptiv LT (Model 977117), Intellis Pro (Model 977118), and Inceptiv (Model 977119) implantable neurostimulators; 2) the Neuro Sense closed-loop stimulation feature for Medtronic Vectris SureScan MRI 1x8 Compact Leads (Models 977A260, 977A275, and 977A290 only); 3) updated Differential Target Multiplexed (DTM) SCS user interface (i.e., the DTM programming style, Spine Anatomy View, and DTM templating feature); and 4) a new wireless recharger (Model WR9230).

Source documents

Other decisions for Medtronic Neuromodulation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.